Credo Technology Group Holding Ltd. — FY2024 Form 10-K
Period: Fiscal year ended April 27, 2024 (52 weeks), compared with fiscal year ended April 29, 2023. Although the request metadata refers to “2023 Q4,” this filing is an annual report and does not provide standalone fourth-quarter results.
Business context
Credo designs and sells high-speed, power-efficient connectivity products and licenses SerDes intellectual property for data infrastructure, including hyperscale data centers and AI/ML networks. Its offerings include integrated circuits, active electrical cables (AECs), SerDes chiplets and IP. The company uses a fabless model and relied exclusively on TSMC for wafer production in FY2024.
Financial performance
| Metric | FY2024 | FY2023 |
|---|---|---|
| Revenue | $193.0 million | $184.2 million |
| Gross profit / gross margin | $119.4 million / 61.9% | $106.2 million / 57.7% |
| Operating loss | $37.1 million | $21.2 million |
| Net loss | $28.4 million | $16.5 million |
| Net loss per share, basic and diluted | $0.18 | $0.11 |
| Operating cash flow | $32.7 million | $(24.6) million |
Revenue increased 4.8%. Product sales grew 2.5% to $145.0 million; product engineering services rose 84.6% to $19.9 million; IP license revenue declined 12.3% to $28.0 million. Product engineering services growth included $15.5 million recognized under a new non-recurring engineering contract. A $10.0 million IP-contract milestone was recognized after a previously applied performance constraint was released.
Gross margin improved 4.2 percentage points, reflecting higher-margin engineering services and product sales margin improvement from 46.9% to 51.4%. However, operating expenses rose 22.8% to $156.5 million, driven primarily by research and development and selling, general and administrative costs, including increased share-based compensation. The resulting operating loss widened; higher other income, principally interest income, partially offset the loss before tax.
Liquidity, cash flows and obligations
At April 27, 2024, Credo reported $66.9 million of cash and cash equivalents, $343.1 million of short-term investments and $485.6 million of working capital. Cash and cash equivalents declined from $108.6 million a year earlier. Management stated that existing cash, cash equivalents and other working capital should meet needs for at least the next 12 months and longer term.
Operating cash flow turned positive, helped by non-cash share-based compensation of $39.0 million and lower inventory; receivables and contract assets increased. Investing cash outflow was $249.5 million, reflecting purchases and maturities of short-term investments as well as $15.7 million of property and equipment purchases. Financing cash inflow was $175.3 million, principally from the company’s December 2023 share offering, which generated $173.4 million net proceeds.
The balance sheet reports no borrowings. Total liabilities were $61.7 million, including operating lease liabilities; non-cancelable manufacturing and technology-license purchase commitments totaled $91.8 million, including $50.5 million scheduled for FY2025. The company also disclosed $27.0 million of committed production-mask purchases for future products.
Material changes, outlook and risks
- Losses and investment: Net loss increased to $28.4 million from $16.5 million as operating expenses outpaced gross-profit growth. Research and development expense increased 24.4% to $95.5 million.
- Tax: The FY2024 income-tax provision was $5.6 million, versus a $1.4 million benefit in FY2023. Credo recorded a $23.3 million valuation allowance, including a fourth-quarter increase after concluding that realization of U.S. deferred tax assets was limited.
- Concentration: Two customers represented 39% and 15% of FY2024 revenue, respectively; the top ten accounted for approximately 86%. Sales are generally purchase-order based, without long-term minimum purchase commitments, and orders may be changed, delayed or canceled.
- Geography and supply: The filing reports 36% of revenue in Hong Kong based on shipment destination for products and contracting-entity location for IP and engineering services; this may not reflect end-customer location. Production concentration in Taiwan, including sole-source wafer fabrication at TSMC, exposes the company to supplier, geopolitical and regional-disruption risks.
- Outlook: The filing gives no quantified revenue or earnings guidance. Management cites AI/ML infrastructure and higher-speed Ethernet connectivity as growth opportunities, while cautioning that market adoption, customer spending, competition, product qualification and execution are uncertain.
- Other matters: FY2024 included $39.0 million of share-based compensation. No litigation was identified as having a material adverse effect, and the auditor gave unqualified opinions on the financial statements and internal control over financial reporting. No cash dividends are planned for the foreseeable future.
Important facts for investors to verify
- Whether customer demand and the reported concentration—particularly the 39% and 15% customer exposures—remain stable, and how end-customer concentration differs from contracting-customer disclosure.
- Whether engineering-services and IP milestone revenue recur, and whether contract assets of $21.6 million convert to billed and collected cash as expected.
- Whether product growth and gross-margin gains can outpace continued R&D, SG&A and share-based compensation expense.
- How much of the $91.8 million purchase commitment is unavoidable, and whether reserved manufacturing capacity and future product-mask spending align with demand.
- Whether the $23.3 million tax valuation allowance, inventory estimates and remaining performance obligations change materially in subsequent filings.
- Whether customer adoption of AI/ML infrastructure, supply availability in Taiwan and trade or export-control developments support the company’s stated growth opportunity.